Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLO-HPV: HPV Vaccination After Stem Cell Transplant
NCT06793410Phase 2Recruiting
- Sponsor
- Region Västra Götaland
- Start
- May 2025
- Primary completion
- Oct 2029
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by Region Västra Götaland. Started May 2025; status: recruiting.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT06793410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06793410.